Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

Clinical trial NCT03783936 · COMPLETED

Trial details

NCT number: NCT03783936
Sponsor: Ashwin Somasundaram
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Esophageal Adenocarcinoma Metastasis HER-2 Gene Amplification

Start date: 2019-01-24
Primary completion: 2020-09-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.